nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—peripheral nervous system neoplasm	0.483	1	CbGaD
Lisinopril—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0546	0.239	CbGbCtD
Lisinopril—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0546	0.239	CbGbCtD
Lisinopril—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0379	0.166	CbGbCtD
Lisinopril—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0233	0.102	CbGbCtD
Lisinopril—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0217	0.0953	CbGbCtD
Lisinopril—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0214	0.0937	CbGbCtD
Lisinopril—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0146	0.0639	CbGbCtD
Lisinopril—ACE—forelimb zeugopod—peripheral nervous system neoplasm	0.00484	0.392	CbGeAlD
Lisinopril—ACE—forelimb—peripheral nervous system neoplasm	0.00243	0.197	CbGeAlD
Lisinopril—ACE—arm—peripheral nervous system neoplasm	0.00209	0.169	CbGeAlD
Lisinopril—ACE—nerve—peripheral nervous system neoplasm	0.00133	0.108	CbGeAlD
Lisinopril—ACE—ganglion—peripheral nervous system neoplasm	0.00131	0.107	CbGeAlD
Lisinopril—Ramipril—BCHE—peripheral nervous system neoplasm	0.0013	0.588	CrCbGaD
Lisinopril—Cilazapril—ABCB1—peripheral nervous system neoplasm	0.000525	0.238	CrCbGaD
Lisinopril—Enalapril—ABCB1—peripheral nervous system neoplasm	0.000386	0.174	CrCbGaD
Lisinopril—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000227	0.0184	CbGeAlD
Lisinopril—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.0004	CcSEcCtD
Lisinopril—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.0004	CcSEcCtD
Lisinopril—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000109	0.000399	CcSEcCtD
Lisinopril—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.000397	CcSEcCtD
Lisinopril—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000396	CcSEcCtD
Lisinopril—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000394	CcSEcCtD
Lisinopril—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000394	CcSEcCtD
Lisinopril—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000108	0.000393	CcSEcCtD
Lisinopril—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000393	CcSEcCtD
Lisinopril—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000392	CcSEcCtD
Lisinopril—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000391	CcSEcCtD
Lisinopril—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000107	0.000391	CcSEcCtD
Lisinopril—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00039	CcSEcCtD
Lisinopril—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000107	0.00039	CcSEcCtD
Lisinopril—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000389	CcSEcCtD
Lisinopril—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000107	0.000388	CcSEcCtD
Lisinopril—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000387	CcSEcCtD
Lisinopril—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000106	0.000385	CcSEcCtD
Lisinopril—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000384	CcSEcCtD
Lisinopril—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000105	0.000384	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000382	CcSEcCtD
Lisinopril—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000105	0.000382	CcSEcCtD
Lisinopril—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000105	0.000381	CcSEcCtD
Lisinopril—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00038	CcSEcCtD
Lisinopril—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000379	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000104	0.000378	CcSEcCtD
Lisinopril—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000104	0.000378	CcSEcCtD
Lisinopril—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000104	0.000378	CcSEcCtD
Lisinopril—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000378	CcSEcCtD
Lisinopril—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000375	CcSEcCtD
Lisinopril—Pain—Etoposide—peripheral nervous system neoplasm	0.000103	0.000375	CcSEcCtD
Lisinopril—Constipation—Etoposide—peripheral nervous system neoplasm	0.000103	0.000375	CcSEcCtD
Lisinopril—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000374	CcSEcCtD
Lisinopril—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000374	CcSEcCtD
Lisinopril—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000374	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000371	CcSEcCtD
Lisinopril—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000371	CcSEcCtD
Lisinopril—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000102	0.00037	CcSEcCtD
Lisinopril—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000369	CcSEcCtD
Lisinopril—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000367	CcSEcCtD
Lisinopril—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000365	CcSEcCtD
Lisinopril—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000364	CcSEcCtD
Lisinopril—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000364	CcSEcCtD
Lisinopril—Epistaxis—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000363	CcSEcCtD
Lisinopril—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000362	CcSEcCtD
Lisinopril—Sinusitis—Epirubicin—peripheral nervous system neoplasm	9.92e-05	0.000361	CcSEcCtD
Lisinopril—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.91e-05	0.000361	CcSEcCtD
Lisinopril—ABCB1—cerebellum—peripheral nervous system neoplasm	9.91e-05	0.00804	CbGeAlD
Lisinopril—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000361	CcSEcCtD
Lisinopril—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.87e-05	0.00036	CcSEcCtD
Lisinopril—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	9.87e-05	0.000359	CcSEcCtD
Lisinopril—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.000358	CcSEcCtD
Lisinopril—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.84e-05	0.000358	CcSEcCtD
Lisinopril—Dizziness—Vincristine—peripheral nervous system neoplasm	9.82e-05	0.000358	CcSEcCtD
Lisinopril—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.8e-05	0.000357	CcSEcCtD
Lisinopril—Rash—Alitretinoin—peripheral nervous system neoplasm	9.72e-05	0.000354	CcSEcCtD
Lisinopril—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.71e-05	0.000354	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.000353	CcSEcCtD
Lisinopril—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.68e-05	0.000352	CcSEcCtD
Lisinopril—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000352	CcSEcCtD
Lisinopril—Headache—Alitretinoin—peripheral nervous system neoplasm	9.66e-05	0.000352	CcSEcCtD
Lisinopril—Renal failure—Doxorubicin—peripheral nervous system neoplasm	9.62e-05	0.00035	CcSEcCtD
Lisinopril—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000349	CcSEcCtD
Lisinopril—Urticaria—Etoposide—peripheral nervous system neoplasm	9.56e-05	0.000348	CcSEcCtD
Lisinopril—Jaundice—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000347	CcSEcCtD
Lisinopril—Rhinitis—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000347	CcSEcCtD
Lisinopril—Abdominal pain—Etoposide—peripheral nervous system neoplasm	9.51e-05	0.000346	CcSEcCtD
Lisinopril—Body temperature increased—Etoposide—peripheral nervous system neoplasm	9.51e-05	0.000346	CcSEcCtD
Lisinopril—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000346	CcSEcCtD
Lisinopril—Hepatitis—Epirubicin—peripheral nervous system neoplasm	9.49e-05	0.000346	CcSEcCtD
Lisinopril—Vomiting—Vincristine—peripheral nervous system neoplasm	9.44e-05	0.000344	CcSEcCtD
Lisinopril—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.42e-05	0.000343	CcSEcCtD
Lisinopril—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000343	CcSEcCtD
Lisinopril—Sweating—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000342	CcSEcCtD
Lisinopril—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	9.37e-05	0.000341	CcSEcCtD
Lisinopril—Rash—Vincristine—peripheral nervous system neoplasm	9.36e-05	0.000341	CcSEcCtD
Lisinopril—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.36e-05	0.000341	CcSEcCtD
Lisinopril—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000341	CcSEcCtD
Lisinopril—Haematuria—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.00034	CcSEcCtD
Lisinopril—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.000339	CcSEcCtD
Lisinopril—Headache—Vincristine—peripheral nervous system neoplasm	9.3e-05	0.000339	CcSEcCtD
Lisinopril—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000337	CcSEcCtD
Lisinopril—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000336	CcSEcCtD
Lisinopril—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	9.18e-05	0.000334	CcSEcCtD
Lisinopril—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.15e-05	0.000333	CcSEcCtD
Lisinopril—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000333	CcSEcCtD
Lisinopril—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.99e-05	0.000327	CcSEcCtD
Lisinopril—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	8.97e-05	0.000327	CcSEcCtD
Lisinopril—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.000326	CcSEcCtD
Lisinopril—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.86e-05	0.000323	CcSEcCtD
Lisinopril—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.85e-05	0.000322	CcSEcCtD
Lisinopril—Nausea—Vincristine—peripheral nervous system neoplasm	8.82e-05	0.000321	CcSEcCtD
Lisinopril—Flushing—Epirubicin—peripheral nervous system neoplasm	8.81e-05	0.000321	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000321	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	8.78e-05	0.00032	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000318	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000316	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000315	CcSEcCtD
Lisinopril—Asthenia—Etoposide—peripheral nervous system neoplasm	8.63e-05	0.000314	CcSEcCtD
Lisinopril—Angiopathy—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000314	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000314	CcSEcCtD
Lisinopril—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	8.55e-05	0.000312	CcSEcCtD
Lisinopril—Chills—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.00031	CcSEcCtD
Lisinopril—Pruritus—Etoposide—peripheral nervous system neoplasm	8.51e-05	0.00031	CcSEcCtD
Lisinopril—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	8.48e-05	0.000309	CcSEcCtD
Lisinopril—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000306	CcSEcCtD
Lisinopril—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.35e-05	0.000304	CcSEcCtD
Lisinopril—Mental disorder—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000303	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000302	CcSEcCtD
Lisinopril—Rash—Cisplatin—peripheral nervous system neoplasm	8.28e-05	0.000302	CcSEcCtD
Lisinopril—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.27e-05	0.000301	CcSEcCtD
Lisinopril—Malnutrition—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000301	CcSEcCtD
Lisinopril—Erythema—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000301	CcSEcCtD
Lisinopril—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.23e-05	0.0003	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	8.19e-05	0.000298	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000297	CcSEcCtD
Lisinopril—Flatulence—Epirubicin—peripheral nervous system neoplasm	8.14e-05	0.000297	CcSEcCtD
Lisinopril—Tension—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000295	CcSEcCtD
Lisinopril—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	8.09e-05	0.000295	CcSEcCtD
Lisinopril—Nervousness—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000292	CcSEcCtD
Lisinopril—Back pain—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000291	CcSEcCtD
Lisinopril—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.00029	CcSEcCtD
Lisinopril—Dizziness—Etoposide—peripheral nervous system neoplasm	7.96e-05	0.00029	CcSEcCtD
Lisinopril—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.000289	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000288	CcSEcCtD
Lisinopril—Chills—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000287	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	7.85e-05	0.000286	CcSEcCtD
Lisinopril—Nausea—Cisplatin—peripheral nervous system neoplasm	7.8e-05	0.000284	CcSEcCtD
Lisinopril—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.79e-05	0.000284	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000283	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.00028	CcSEcCtD
Lisinopril—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	7.67e-05	0.000279	CcSEcCtD
Lisinopril—Vomiting—Etoposide—peripheral nervous system neoplasm	7.65e-05	0.000279	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000278	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000278	CcSEcCtD
Lisinopril—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000278	CcSEcCtD
Lisinopril—Rash—Etoposide—peripheral nervous system neoplasm	7.59e-05	0.000276	CcSEcCtD
Lisinopril—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.58e-05	0.000276	CcSEcCtD
Lisinopril—Headache—Etoposide—peripheral nervous system neoplasm	7.54e-05	0.000275	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000274	CcSEcCtD
Lisinopril—Tension—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000273	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000273	CcSEcCtD
Lisinopril—Malaise—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000271	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.00027	CcSEcCtD
Lisinopril—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.00027	CcSEcCtD
Lisinopril—Syncope—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.00027	CcSEcCtD
Lisinopril—Leukopenia—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000269	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000269	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000268	CcSEcCtD
Lisinopril—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000266	CcSEcCtD
Lisinopril—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	7.26e-05	0.000265	CcSEcCtD
Lisinopril—Cough—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000263	CcSEcCtD
Lisinopril—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.21e-05	0.000262	CcSEcCtD
Lisinopril—Nausea—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.00026	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000258	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000257	CcSEcCtD
Lisinopril—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000256	CcSEcCtD
Lisinopril—Arthralgia—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000256	CcSEcCtD
Lisinopril—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000256	CcSEcCtD
Lisinopril—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.01e-05	0.000255	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.99e-05	0.000254	CcSEcCtD
Lisinopril—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000253	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000251	CcSEcCtD
Lisinopril—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000251	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.00025	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.00025	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000249	CcSEcCtD
Lisinopril—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000248	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000246	CcSEcCtD
Lisinopril—Oedema—Epirubicin—peripheral nervous system neoplasm	6.74e-05	0.000246	CcSEcCtD
Lisinopril—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.74e-05	0.000246	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.72e-05	0.000245	CcSEcCtD
Lisinopril—Infection—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000244	CcSEcCtD
Lisinopril—Cough—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000243	CcSEcCtD
Lisinopril—Shock—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000242	CcSEcCtD
Lisinopril—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000241	CcSEcCtD
Lisinopril—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.58e-05	0.00024	CcSEcCtD
Lisinopril—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.000239	CcSEcCtD
Lisinopril—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000237	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000237	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000237	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000237	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.000236	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000235	CcSEcCtD
Lisinopril—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000234	CcSEcCtD
Lisinopril—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000234	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	0.000232	CcSEcCtD
Lisinopril—Hypotension—Epirubicin—peripheral nervous system neoplasm	6.3e-05	0.00023	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000229	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000227	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000227	CcSEcCtD
Lisinopril—Infection—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000226	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000224	CcSEcCtD
Lisinopril—Shock—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000224	CcSEcCtD
Lisinopril—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000223	CcSEcCtD
Lisinopril—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.1e-05	0.000222	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000222	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000221	CcSEcCtD
Lisinopril—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000221	CcSEcCtD
Lisinopril—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.00022	CcSEcCtD
Lisinopril—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000219	CcSEcCtD
Lisinopril—Somnolence—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000218	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000217	CcSEcCtD
Lisinopril—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000216	CcSEcCtD
Lisinopril—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.000214	CcSEcCtD
Lisinopril—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000212	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.000212	CcSEcCtD
Lisinopril—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000212	CcSEcCtD
Lisinopril—Constipation—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.00021	CcSEcCtD
Lisinopril—Pain—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.00021	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000207	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000206	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000204	CcSEcCtD
Lisinopril—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000203	CcSEcCtD
Lisinopril—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.56e-05	0.000202	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000202	CcSEcCtD
Lisinopril—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000201	CcSEcCtD
Lisinopril—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.0002	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.000198	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.39e-05	0.000196	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000196	CcSEcCtD
Lisinopril—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000195	CcSEcCtD
Lisinopril—Pain—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000194	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000194	CcSEcCtD
Lisinopril—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000194	CcSEcCtD
Lisinopril—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000194	CcSEcCtD
Lisinopril—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.000187	CcSEcCtD
Lisinopril—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000186	CcSEcCtD
Lisinopril—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000181	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000181	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.00018	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.00018	CcSEcCtD
Lisinopril—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000176	CcSEcCtD
Lisinopril—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000174	CcSEcCtD
Lisinopril—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000168	CcSEcCtD
Lisinopril—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000167	CcSEcCtD
Lisinopril—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000163	CcSEcCtD
Lisinopril—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000162	CcSEcCtD
Lisinopril—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000161	CcSEcCtD
Lisinopril—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.000156	CcSEcCtD
Lisinopril—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000156	CcSEcCtD
Lisinopril—Rash—Epirubicin—peripheral nervous system neoplasm	4.25e-05	0.000155	CcSEcCtD
Lisinopril—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.25e-05	0.000155	CcSEcCtD
Lisinopril—Headache—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000154	CcSEcCtD
Lisinopril—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.00015	CcSEcCtD
Lisinopril—Nausea—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000146	CcSEcCtD
Lisinopril—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000145	CcSEcCtD
Lisinopril—Rash—Doxorubicin—peripheral nervous system neoplasm	3.93e-05	0.000143	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.93e-05	0.000143	CcSEcCtD
Lisinopril—Headache—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.000142	CcSEcCtD
Lisinopril—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000135	CcSEcCtD
